The Biomedical Advanced Research and Development Authority (BARDA) develops and purchases the necessary vaccines, drugs, therapies, and diagnostic tools for public health medical emergencies. Interestingly, between 2010 and 2012, BARDA experienced a budget increase of some 60% from $337.5M to roughly $547M. For Life Science organizations, this translates into hundreds of millions of dollars in potential […]
FreeMind is proud to host the Michael J. Fox Foundation on the upcoming summer educational webinar focusing on Parkinson’s and other Neurological disorders. Parkinson’s is a complex disease that varies greatly among affected individuals. For The Michael J. Fox Foundation, there is one clear measure of success: delivering patients better treatments and, ultimately, a cure for Parkinson’s disease. Today, MJFF is […]
Assembling a budget for your grant is typically the last item to be addressed. Reason being that the figures you are suggesting must reflect the work you are proposing to complete. That said, simply stating the cost per item is hardly enough, and a properly constructed justification is mandatory and weighs heavily on approval of […]
FreeMind’s VP Ayal Ronen will discuss the SBIR/STTR program viewed by many as a critical source of funding for the Small Business Life Science community. Through the SBIR/STTR program some $700,000,000 are awarded annually by the NIH specifically to research project grants. Despite a continuous decline in success rates, this remains a crucial path small businesses must […]
Listen to the podcast Though money is flowing more freely into the biotech sector these days, one consequence of the financial turmoil of recent years has been that it’s forced companies to think more broadly about their funding sources. At the same time, a greater emphasis on translational research and increased funding to the National […]